Purchases and Sales Made in Q4 2022 in Autolus Therapeutics PLC (AUTL)
This table provides information about the institutional ownership of Autolus Therapeutics PLC (AUTL) during Q4 2022. The information is specifically focused on institutions that hold shares of Autolus Therapeutics plc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-14.2K- 3.64% |
$24.7K - $46.4K
|
376K
$1.12M
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-24.8K- 59.31% |
$43.1K - $81K
|
17K
$50.8K
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-34.6K- 7.74% |
$60.2K - $113K
|
412K
$1.23M
|
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-79.7K- 59.73% |
$139K - $261K
|
53.7K
$161K
|